News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Clinical Trials Arena47d agobullish
J&J’s Intra-Cellular buy continues to bear fruit with Caplyta bipolar winBioPharma Dive86d agobullish
Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene24/7 Wall St.89d agobullish
Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles ConsensusBenzinga107d agobullish
FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery SystemReuters109d agobullish
J&J enters US robotic surgery market after device gets marketing authorizationMotley Fool112d agobullish
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report?InvestorsHub116d agobullish
Johnson & Johnson tops second-quarter forecasts and lifts guidance despite premarket decline (JNJ)Reuters116d agobullish
J&J quarterly earnings beat Wall Street estimates on strength of medicines unit